ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,659.60
      -2.28%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.115
      0.01%
      Bitcoin
      56,763.01
      -1.02%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Adamas Pharmaceuticals Inc (ADMS)

      7. Adamas Pharmaceuticals Inc (ADMS) News

      ADMS

      Adamas Pharmaceuticals (ADMS)

      Adamas Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ADMS
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      06/22/20189:12AMGlobeNewswire Inc.Adamas Presents New Data Analysis Demonstrating that GOCOVRI™ Reduces Transitions between Dyskinesia and OFF Episodes Throu...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/08/20185:55PMGlobeNewswire Inc.Adamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/07/20185:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/07/20185:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/07/20185:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/07/20185:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/07/20185:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/07/20185:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/07/20185:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/07/20184:30PMGlobeNewswire Inc.Adamas to Present at Two Upcoming Investor ConferencesNASDAQ:ADMSAdamas Pharmaceuticals Inc
      06/06/20184:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/24/20189:05AMGlobeNewswire Inc.Adamas Announces Publication of Pharmacokinetic Data for GOCOVRI™ in Clinical PharmacokineticsNASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/09/20184:05PMGlobeNewswire Inc.Adamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/03/20184:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/03/20184:05PMGlobeNewswire Inc.Adamas Reports First Quarter 2018 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/03/20184:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      05/02/20183:22PMGlobeNewswire Inc.Adamas to Present at Two Upcoming Investor ConferencesNASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/26/20184:06PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/26/20184:05PMGlobeNewswire Inc.Adamas to Announce First Quarter 2018 Financial Results and Host Conference Call on May 3, 2018NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/26/20184:04PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/24/20184:30PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/19/20185:30AMGlobeNewswire Inc.Adamas Announces Final Results from the Two-Year Phase 3 Open-Label Study of GOCOVRI™ in Parkinson’s Disease Patients wit...NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/12/20185:09PMGlobeNewswire Inc.Adamas Announces Multiple Data Presentations at the American Academy of Neurology Annual MeetingNASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/10/20188:46AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      04/03/20189:00AMGlobeNewswire Inc.Adamas Announces First Patient Enrolled in Phase 3 Trial of ADS-5102 in Multiple Sclerosis Patients with Walking ImpairmentNASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/22/20185:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/22/20185:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/22/20185:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
      03/22/20185:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ADMS

      Your Recent History

      BIT
      P1QL66
      BNP Paribas Issuance
      Delayed Upgrade Clock